GYNAECOLOGY CANCER RESEARCH FUND
Registered charity 1091708 · accounts filings on the Charity Commission register · also known as EVE APPEAL, GCRF, GYNAECOLOGICAL CANCER RESEARCH UK, GYNAECOLOGICAL CANCER UK, GYNAECOLOGY CANCER RESEARCH UK, GYNAECOLOGY CANCER UK · also registered in Scotland as SC042612 (OSCR)
The Eve Appeal's vision is a future where fewer women develop and more women survive the five gynaecological cancers. To achieve this vision we raise money to support and fund world-class research into the five gynaecological cancers alongside raising awareness of them. The five gynaecological cancers are ovarian, cervical, vulval, vaginal and womb (also known as endometrial or uterine).
Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts
Financial health, per its FY2024 accounts
The accounts state that the charity ended the year with a surplus of £470,402 in unrestricted reserves, which is £290,402 above its agreed operating reserves target of £180,000. The charity reports a total cash balance of £1,060,129 and confirms that it has adequate resources to continue in operation for the foreseeable future with no material uncertainties.
Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.
What the accounts disclose
Related-party transaction: Donations from trustees
“During the year under review, the charity received income totalling £18,070 in donations from 9 Trustees, both current and resigned in the period, including partners (2023: £20,254 from 7 Trustees including partners). Reed Smith LLP provided pro bono legal services and other support to the charity totalling £80,116 (2023: 14,989). Tamara Box, a partner at Reed Smith LLP is also chair of board of trustee of the charity.” — page 50
Per its FY2024 accounts as filed with the Charity Commission.
Trading subsidiary: Eve Appeal Limited
“The Charity had one 100% owned subsidiary company in the year. Eve Appeal Limited is a trading company that distributes its profits under Gift Aid to the Charity.” — page 21
Per its FY2024 accounts as filed with the Charity Commission.
Accounts audited by Moore Kingston Smith LLP. Discloses 3 of 6 completeness components.
Corporate structure
Company officers (Companies House)
Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.
- LEVY, Julia Anna — director, appointed 21/05/2026on trustee list
- BYRNE, Katharine Helen — director, appointed 05/02/2025on trustee list
- DEAN, Emma — director, appointed 18/10/2023on trustee list
- O'HARA, Marion Rachel — director, appointed 27/10/2021on trustee list
- ROSENTHAL, Adam, Prof. — director, appointed 26/10/2020on trustee list
- EKECHI, Christine, Dr — director, appointed 26/10/2020on trustee list
- BOX, Mary Tamara — director, appointed 01/07/2020on trustee list
- MORRIS, Sarah Louise — director, appointed 19/12/2019on trustee list
- COSEC DIRECT LIMITED — corporate secretary, appointed 29/10/2009
Official officers record.
Structured financials (annual return, FY ending 31/12/2024)
Cost of raising funds
£584k
Reported reserves equal ~1.3 months of spending — in the bottom quarter for charities its size (median 4.8 months; benchmarks).
Per its annual return, cost of raising funds: 32.8% of total income — in the top quarter for charities its size (median 5.2%) (benchmarks).
Register events
- Received assets from another charity (02/01/2018) — per the register’s event history; asset transfers typically record mergers or reorganisations.
Trustee list from the Charity Commission register (current, not historical).
Operates in: Northern Ireland · Scotland · Throughout England And Wales · United States
Income and spending
Common questions
Is GYNAECOLOGY CANCER RESEARCH FUND financially healthy?
Per its FY2024 accounts: The accounts state that the charity ended the year with a surplus of £470,402 in unrestricted reserves, which is £290,402 above its agreed operating reserves target of £180,000. The charity reports a total cash balance of £1,060,129 and confirms that it has adequate resources to continue in operation for the foreseeable future with no material uncertainties. Its FY2024 accounts were audited by Moore Kingston Smith LLP.
Who funds GYNAECOLOGY CANCER RESEARCH FUND?
Funders whose own accounts filings name GYNAECOLOGY CANCER RESEARCH FUND as a grant recipient include THE ORR MACKINTOSH FOUNDATION LIMITED, THE INMAN CHARITY, THE PETER STEBBINGS MEMORIAL CHARITY, THE GROCERS' CHARITY, SCHRODER CHARITY TRUST.
Known funders
Grants to this charity found in funders’ own accounts filings.
Government & lottery funding
Grants to this charity published as open data by government and lottery funders (360Giving).
Funders of similar charities
Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.
Charities like this
Semantically similar by activities and financial character, from our analysed corpus. Compare with OVARIAN CANCER ACTION.
Side by side with its peers
Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.